ANANDA Developments has announced a number of heavyweight hires including a new COO, Head of Cultivation and Head of Plant Science, sending its stock...
MGC Pharmaceutical has reported its strongest ever quarterly sales figures, but a lack of significant progress on its drug trials and regulatory approvals saw...
GLASS Pharms has agreed a £22.5m funding deal to build the UK mainland’s first, high-THC, commercial cultivation facility for over 20 years.
The deal will...
As Europe embraces medicinal cannabis the continent’s prescribing landscape is developing different characteristics to that of the US.
AFTER picking up their script from a...
AFTER launching a patient registry earlier this year further signs the UK’s National Health Service is warming to cannabis medicine have emerged with news...
ONE of the UK’s fastest growing and largest cannabis companies has launched its first European operation with more to follow over the coming months.
The...
ANANDA Developments has secured £300,000 to build out the first phase of its medicinal cannabis growing research facility in Lincolnshire.
In May last year the...
A PERMANENT solution to the import impasse on children’s epilepsy cannabis medication has emerged with the Dutch manufacturer set to see the medicines made...
Pierre Van Weperen of Grow Pharma on the post-Brexit issue surrounding the import of epilepsy cannabis medicines into the UK.
MAINTAINING existing quality standards was...
THE NHS is to launch is first-ever cannabis patient registry in a move which signifies an ambition for the medicines to become more widely-available...
NEW Government figures show a 900% increase in the number of cannabis medicines notified for import demonstrating the private sector’s growing role in fulfilling...
PATIENTS currently frozen out by an under-performing National Health Service are being offered access to cannabis medicine through a new private sector scheme.
Around 700...
A LACK of clinical evidence is a key reason the National Health Service offers for the paucity of medicinal cannabis prescriptions in the UK.
So, one...
A WORLD-LEADING cannabis professor says the UK is caught in a depressing Catch-22 with companies unwilling to invest in clinical trials and medics unwilling...
UK MEDICAL cannabis distributor Grow Pharma has boosted its patient product range by 20% after striking a new deal with Althea Group Holdings.
Grow Pharma...
POKO Innovations an award-winning UK-based collection of CBD-focused companies that bring innovative, inspiring solutions to the CBD industry through...